Native Hawaiian and Pacific Islander Adults Have High CVD Mortality

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 16, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Oct. 15, 2024 -- Native Hawaiian and Pacific Islander (NHPI) adults have a high rate of cardiovascular disease (CVD) mortality, according to a study published online Oct. 15 in the Annals of Internal Medicine.

Rebecca C. Woodruff, Ph.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues describe CVD mortality among NHPI adults using mortality rates from the National Vital Statistics System for 2018 to 2022 for 50 states and the District of Columbia for adults aged 35 years or older at the time of death.

The researchers identified 10,870 CVD deaths (72.6 percent for heart disease and 19.0 percent from cerebrovascular disease) among NHPI adults from 2018 to 2022. For NHPI adults, the CVD age-standardized mortality rate (ASMR) was 1.5 times higher than for Asian adults (369.6 versus 243.9 deaths per 100,000 persons). NHPI adults had the third highest CVD ASMR in the country, after Black and White adults (558.8 and 423.6 deaths per 100,000 people, respectively).

"Results from this analysis suggest that NHPI adults have a high rate of death from CVD, which has previously been masked by aggregation of the NHPI population with the Asian population," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-16 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords